AML (Acute Myeloid Leukemia),Leukemia Best Transplant Choices for Low and Intermediate-Risk AML Jun 04, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Cancer Cell Cycle Control: Integrating Gene Regulation and Therapy Jun 04, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Impact of MRD Negativity and Post-Remission in Adult B-ALL May 28, 2024
AML (Acute Myeloid Leukemia),Leukemia Prognostic Role of EMI and GO Treatment in Pediatric AML May 27, 2024
AML (Acute Myeloid Leukemia),Leukemia Venetoclax and Hypomethylating Agents vs HAG in AML May 20, 2024
AML (Acute Myeloid Leukemia),Leukemia Efficacy of GO-Based AML Treatment: Low vs. Intermediate Risk May 15, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Enhancing CAR T-Cell Therapy in Leukemia: Beyond CD22 May 14, 2024
